HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J acquires Chinese cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Firm adds Beijing Dabao Cosmetics - whose skin-care offerings include SOD Milk Cream and SOD Protein Milk, which rely on superoxide dismutase to reduce free-radical damage - to its growing portfolio of brands sold in China. "Dabao is a successful brand in the China market, and a brand we respect," says Jesse Wu, president of Johnson & Johnson (China) Investment Co. "This transaction is an extension of our commitment to China and to the continued development of China's consumer health-care sector." J&J will develop brand with help of Dabao's "unsurpassed local market knowledge," Wu notes. J&J holdings Johnson's Baby, Neutrogena and Clean & Clear are already available to Chinese consumers. Firm is official partner of Beijing 2008 Olympic Games and Paralympic Games and has launched Johnson & Johnson Family Health Initiative in the country. All government approvals were complete at time of announcement; financial terms were not disclosed...

You may also be interested in...



J&J on consumer biz

Emerging markets, including China, Brazil, Russia and India, offer "fertile ground for the consumer business to grow" and will likely lead the business segment on the road to recovery, Johnson & Johnson says during March 2 RBC Capital Markets Healthcare Conference in which it discussed its business relative to the recession. Marketer of Neutrogena, Clean & Clear and Aveeno skin-care lines already has made selective acquisitions in developing markets to "gain a foothold into certain tiers" of the consumer segment where it did not formerly compete. The most significant of those acquisitions was Dabao skin care in China (1"The Rose Sheet" Aug. 4, 2008, In Brief). J&J's international skin-care sales grew 14.2% on a reported basis in its fourth quarter, as announced in late January (2"The Rose Sheet" Feb. 1, 2010)

“High-Quality” Skin Care, Listerine Lead J&J Consumer Sales In Q1

Johnson & Johnson's skin care business was the bright spot of the company's U.S. consumer products segment during the first quarter, growing double digits on the strength of "high-quality" formulas, the firm said

J&J Has Soft Sales Across U.S. Consumer Biz., Keeps Focus On Growth Abroad

Johnson & Johnson's consumer division looks to expansion and innovation in developing markets to help recover after a fourth quarter slip in sales, the company suggested during a fourth-quarter and year-end call Jan. 20

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015579

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel